{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Treatment of pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive",
    "geneContextQualifier": "ALK",
    "objectTherapeutic": "Crizotinib [Xalkori]"
}